Copertina

Clinical trials on drug repositioning for COVID-19 treatment

The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genus Betacoronavirus, that is dis...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Sandro G. Viveiros Rosa (Autore), Wilson C. Santos (Autore)
Natura:	Libro
Pubblicazione:	Pan American Health Organization, 2020-03-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
di: Josidel Conceição Oliver, et al.
Pubblicazione: (2022)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
di: Yong Li, et al.
Pubblicazione: (2020)

Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
di: Piero Sestili, et al.
Pubblicazione: (2020)

Changing Trends in Computational Drug Repositioning
di: Jaswanth K. Yella, et al.
Pubblicazione: (2018)

Drug Repositioning in Glioblastoma: A Pathway Perspective
di: Sze Kiat Tan, et al.
Pubblicazione: (2018)

Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician's perspective
di: A. B. Bayoumy, et al.
Pubblicazione: (2020)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer's Disease
di: Clive Ballard, et al.
Pubblicazione: (2013)

Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
di: Alessia Greco, et al.
Pubblicazione: (2023)

In Silico Strategies for Prospective Drug Repositionings
Pubblicazione: (2022)

In Silico Strategies for Prospective Drug Repositionings
Pubblicazione: (2023)

Drug repositioning: A bibliometric analysis
di: Guojun Sun, et al.
Pubblicazione: (2022)

Overcoming Obstacles to Drug Repositioning in Japan
di: Yuhei Nishimura, et al.
Pubblicazione: (2017)

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
di: Medi Kori, et al.
Pubblicazione: (2022)

Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
di: Hanne-Line Rabben, et al.
Pubblicazione: (2021)

A computational multi-targeting approach for drug repositioning for psoriasis treatment
di: Akachukwu Ibezim, et al.
Pubblicazione: (2021)

Knowledge Mapping of Drug Repositioning’s Theme and Development
di: Lang X, et al.
Pubblicazione: (2023)

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
di: Giovanna Menduti, et al.
Pubblicazione: (2020)

A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis
di: Albert Li, et al.
Pubblicazione: (2022)

Drug Repositioning: Current Advances and Future Perspectives
di: Yuhei Nishimura
Pubblicazione: (2019)

Enhancing the Promise of Drug Repositioning through Genetics
di: Jayne-Louise E. Pritchard, et al.
Pubblicazione: (2017)

Madrasah Reposition in Building Community Trust in Covid-19 Era Disruption
di: Ahmad Salim, et al.
Pubblicazione: (2021)

Vector competence of Culex mosquitoes (Diptera: Culicidae) in Zika virus transmission: an integrative review
di: Sandro G. Viveiros-Rosa, et al.
Pubblicazione: (2020)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
di: Yuhei Nishimura, et al.
Pubblicazione: (2018)

Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach
di: Alexia Barbarossa, et al.
Pubblicazione: (2022)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
di: Yoshihiro Noguchi, et al.
Pubblicazione: (2023)

Lip repositioning
di: Reetika Gaddale, et al.
Pubblicazione: (2014)

Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
di: Paulina Glajzner, et al.
Pubblicazione: (2024)

Drug Repositioning Ketamine as a New Treatment for Bipolar Disorder Using Text Mining
di: Shivani Manikandan, et al.
Pubblicazione: (2021)

Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
di: Sheila I. Peña-Corona, et al.
Pubblicazione: (2023)

Lung adenocarcinoma-related target gene prediction and drug repositioning
di: Rui Xuan Huang, et al.
Pubblicazione: (2022)

Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning
di: Sarah Rouhana, et al.
Pubblicazione: (2021)

Globalisation in the time of COVID-19: repositioning Africa to meet the immediate and remote challenges
di: Sanni Yaya, et al.
Pubblicazione: (2020)

Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold
di: Francisco José Roma Paumgartten, et al.

Current trends and future prospects of drug repositioning in gastrointestinal oncology
di: Nayeralsadat Fatemi, et al.
Pubblicazione: (2024)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
di: Hermann A. M. Mucke
Pubblicazione: (2017)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
di: Raúl A. Mejía-Pedroza, et al.
Pubblicazione: (2018)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
di: Song Lei, et al.
Pubblicazione: (2022)

Network module‐based drug repositioning for pulmonary arterial hypertension
di: Rui‐Sheng Wang, et al.
Pubblicazione: (2021)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
di: Zhichao Liu, et al.
Pubblicazione: (2021)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
di: Yoshito Zamami, et al.
Pubblicazione: (2021)